Version 2.78

Description

Besifloxacin (INN/USAN) is a fourth-generation fluoroquinolone antibiotic. The marketed compound is besifloxacin hydrochloride. It was developed by SSP Co. Ltd., Japan, and designated SS734. SSP licensed U.S. and European rights to SS734 for ophthalmic use to InSite Vision Incorporated (OTCBB: INSV) in 2000. InSite Vision developed an eye drop formulation (ISV-403) and conducted preliminary clinical trials before selling the product and all rights to Bausch & Lomb in 2003. The eye drop was approved by the United States Food and Drug Administration (FDA) on May 29, 2009 and marketed under the trade name Besivance. Besifloxacin has been found to inhibit production of pro-inflammatory cytokines in vitro. Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details. Source: Wikipedia, Besifloxacin

Basic Part Properties

Part Display Name
Besifloxacin
Part Type
Component (Describes the core component or analyte measured)
Created On
2013-01-30
Construct for LOINC Short Name
Besifloxacin

LOINC Terminology Service (API) using HL7® FHIR® Get Info

CodeSystem lookup
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP172556-5
ConceptMap translate
https://fhir.loinc.org/ConceptMap/$translate?system=http://loinc.org&code=LP172556-5

Language Variants Get Info

Tag Language Translation
zh-CN Chinese (China) 贝西沙星
Synonyms: 氟喹诺酮类药物;盐酸贝西沙星;Besifloxacin hydrochloride;(R)-7-[3-氨基六氢-1H-氮杂卓-1-基]-8-氯-1-环丙基-6-氟-1,4-二氢-4-氧代-3-羧酸喹啉盐酸盐;CAS 405165-61-9;C19H21ClFN3O3·HCl;®-7-(3-Aminohexahydro-1H-azepin-1-yl)-8-chloro-1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid hy
es-ES Spanish (Spain) Besifloxacino
it-IT Italian (Italy) Besifloxacina
tr-TR Turkish (Turkey) Besiflokzasin
ru-RU Russian (Russian Federation) Безифлоксацин
nl-NL Dutch (Netherlands) besifloxacine